Buy, hold, sell: CBA, QBE, and Qantas shares

Let's see what analysts are saying about these shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are plenty of ASX shares for investors to choose from.

To narrow things down, let's see what analysts are saying about three popular shares, courtesy of The Bull. Here's what they are recommending:

A young man goes over his finances and investment portfolio at home.

Image source: Getty Images

Commonwealth Bank of Australia (ASX: CBA)

The team at Medallion is siding with the majority of brokers by declaring CBA shares as sell.

While acknowledging that CBA is the highest-quality Australian bank, it feels that its valuation is stretched.

Medallion also highlights that its shares are trading at a significant premium to peers despite having similar earnings growth outlook. It said:

CBA remains the highest quality franchise among Australia's major banks, but the valuation now looks stretched. The stock trades on a price-to-earnings multiple well above its peers despite similar earnings growth prospects. The recent annual dividend yield around 3 per cent is modest compared with other income opportunities.

With credit growth slowing and net interest margins stabilising, we believe earnings momentum is unlikely to justify such a premium valuation. After a strong share price run, investors may want to consider taking profits and reallocating capital to more attractively valued opportunities.

QBE Insurance Group Ltd (ASX: QBE)

Over at DP Wealth Advisory, its analysts have named this insurance giant as a hold this week.

It acknowledges that QBE is a well-managed company, but has concerns over challenging trading conditions. It explains:

QBE is a well managed global business with a strong return on equity and improving profit margins. Adjusted return on equity was 19.8 per cent in full year 2025 compared to 18.2 per cent in the prior corresponding period. Gross written premiums grew 7 per cent. Insurance companies rely on investment returns, which is challenging in a volatile global market. We retain a hold recommendation given QBE is trading near a 12 month consensus valuation.

Qantas Airways Ltd (ASX: QAN)

Finally, due to the prospect of jet fuel prices steering higher for longer, the team at DP Advisory is staying clear of Qantas shares for the time being.

As a result, it has named the Flying Kangaroo as a sell this week and believes there are better options out there for investors. It said:

Qantas is a well managed domestic and international airline, holding a 70 per cent market share in Australia. The shares were trading at $10.65 on February 25, a day prior to the company posting its first half year result in fiscal year 2026. The stock was trading at $8.46 on March 19. Qantas announced on March 13, 2026 that it had settled a class action for $105 million regarding flight credits during COVID-19. The company has hedged jet fuel supply prices in the shorter term, but I'm concerned about the impact of possibly higher crude oil prices over the longer term.

I'm also mindful of the expense involved in Qantas upgrading its airline fleet after years of under investment by previous management as well as COVID-19. Qantas has a high fixed cost base. In my view, it's a cyclical stock due to its reliance on consumer and business sentiment. Other stocks appeal more at this point.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »

Wlorker on a laptop on top of solar panels.
Broker Notes

Up 8%, should I buy the rebound in Origin Energy shares today?

A leading analyst provides his forecast for Origin Energy’s rebounding shares.

Read more »

A woman stands in a field and raises her arms to welcome a golden sunset.
Gold

4 ASX 200 gold shares to buy: Experts

Experts explain their buy ratings following these miners' June quarter reports.

Read more »

Three balls at various places on a cycle.
Broker Notes

6 ASX uranium shares to buy ahead of yellow cake rising to US$200 per pound: experts

This broker tips 83% to 295% upside over 12 months for its 6 top ASX uranium share picks.

Read more »